已收盘 02-06 16:00:00 美东时间
+0.220
+1.42%
Despite reporting a mixed Q4 performance, HCA Healthcare (HCA) rose ~7% in the premarket on Tuesday after the nation’s largest for-profit hospital operator announced new share buybacks and boosted its...
01-27 20:59
Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2025 Results Select Medical Holdings Corporation will release its fourth quarter and full year 2025 financial results on Thursday, February 19, 2026, after the market closes. Results will be available at the Select Medical
01-22 05:16
U.S. stocks were mixed, with the Dow Jones gaining around 100 points on Tuesday...
2025-11-25 23:03
Select Medical ( ($SEM) ) has shared an update. On November 24, 2025, Select Me...
2025-11-25 21:44
MECHANICSBURG, Pa., Nov. 24, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) has received a non-binding indication of interest f...
2025-11-25 09:30
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Select Medical业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **整体业绩表现:** - 合并营收达到13.6亿美元,同比增长超过7%(上年同期为12.7亿美元) - 调整后EBITDA为1.117亿美元,同比增长超过7%(上年同期为1.039亿美元) - 持续经营业务每股收益为0.23美元,同比增长超过21%(上年同期为0.19美元) **分业务板块表现:** - 住院康复业务:营收3.286亿美元,同比增长16%;调整后EBITDA为6800万美元,同比增长13% - 门诊康复业务:营收3.254亿美元,同比增长4%
2025-11-03 12:25
Select Medical Hldgs (NYSE:SEM) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.15 by 51.32 percent. This is a 11.54 percent decrease over earnings of $0.26 per share from
2025-10-31 04:31
2025 Full Year Guidance:The Company updated its full year 2025 guidance, incorporating the expected 2025 performance of the SEM business. Net sales is expected to be in the range of $3.39 billion to $3.45 billion.
2025-10-28 19:32
Hospital stocks are expected to trade higher on Friday after HCA Healthcare (NYSE:HCA), the number one for-profit healthcare provider in the U.S., and its peer Community Health Systems (NYSE:CYH) repo...
2025-10-24 19:57
今日重点评级关注:富国银行:维持Kyverna Therapeutics"超配"评级,目标价从24美元升至27美元;Chardan Capital:维持Oculis Holding"买入"评级,目标价从33美元升至51美元
2025-10-09 10:51